📰 Vanda Pharma News
Vanda Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vanda Pharma. Real-time updates on events, politics, business and more.
April 3, 2024
Vanda Pharmaceuticals announces the FDA approval of iloperidone (Fanapt) for the acute treatment of bipolar 1 disorder.
February 7, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
October 3, 2023
  On Tuesday, 647 companies set new 52-week lows.
August 30, 2023
  On Wednesday, 59 companies achieved new lows for the year.
August 3, 2023
  During Thursday's session, 92 stocks hit new 52-week lows.
July 20, 2023
Non-24-hour Sleep-wake Disorder Treatment Market 2023 Forecast: Unveiling Opportunities and Growth Non-24-hour Sleep-wake Disorder Treatment Market re
July 20, 2023
Jet Lag Medication Market 2023 Forecast: Unveiling Opportunities and Growth Jet Lag Medication Market research report helps to recognize the market ch